-
1
-
-
0037221767
-
TP53 and breast cancer
-
Borresen-Dale AL. TP53 and breast cancer. Hum Mutat 2003;21:292-300.
-
(2003)
Hum Mutat
, vol.21
, pp. 292-300
-
-
Borresen-Dale, A.L.1
-
2
-
-
0033885192
-
TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer
-
Overgaard J, Yilmaz M, Guldberg P, Hansen LL, Alsner J. TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer. Acta Oncol 2000;39:327-33.
-
(2000)
Acta Oncol
, vol.39
, pp. 327-333
-
-
Overgaard, J.1
Yilmaz, M.2
Guldberg, P.3
Hansen, L.L.4
Alsner, J.5
-
3
-
-
0033766175
-
Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
-
Alsner J, Yilmaz M, Guldberg P, Hansen LL, Overgaard J. Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients. Clin Cancer Res 2000;6:3923-31.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 3923-3931
-
-
Alsner, J.1
Yilmaz, M.2
Guldberg, P.3
Hansen, L.L.4
Overgaard, J.5
-
4
-
-
0027983669
-
Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations
-
Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 1994;265:346-55.
-
(1994)
Science
, vol.265
, pp. 346-355
-
-
Cho, Y.1
Gorina, S.2
Jeffrey, P.D.3
Pavletich, N.P.4
-
5
-
-
0030448650
-
Identification of a novel p53 functional domain that is necessary for efficient growth suppression
-
U S A
-
Walker KK, Levine AJ. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci U S A 1996;93:15335-40.
-
(1996)
Proc Natl Acad Sci
, vol.93
, pp. 15335-15340
-
-
Walker, K.K.1
Levine, A.J.2
-
6
-
-
0023125537
-
Primary structure polymorphism at amino acid residue 72 of human p53
-
Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 1987;7:961-3.
-
(1987)
Mol Cell Biol
, vol.7
, pp. 961-963
-
-
Matlashewski, G.J.1
Tuck, S.2
Pim, D.3
Lamb, P.4
Schneider, J.5
Crawford, L.V.6
-
8
-
-
0642314312
-
P53 codon 72 polymorphism in breast cancer
-
Buyru N, Tigli H, Dalay N. P53 codon 72 polymorphism in breast cancer. Oncol Rep 2003;10:711-4.
-
(2003)
Oncol Rep
, vol.10
, pp. 711-714
-
-
Buyru, N.1
Tigli, H.2
Dalay, N.3
-
9
-
-
1542546270
-
Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer
-
Huang XE, Hamajima N, Katsuda N, Matsuo K, Hirose K, Mizutani M, et al. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer. Breast Cancer 2003;10:307-11.
-
(2003)
Breast Cancer
, vol.10
, pp. 307-311
-
-
Huang, X.E.1
Hamajima, N.2
Katsuda, N.3
Matsuo, K.4
Hirose, K.5
Mizutani, M.6
-
10
-
-
2942627405
-
Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women
-
Noma C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S. Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women. Cancer Lett 2004;210:197-203.
-
(2004)
Cancer Lett
, vol.210
, pp. 197-203
-
-
Noma, C.1
Miyoshi, Y.2
Taguchi, T.3
Tamaki, Y.4
Noguchi, S.5
-
11
-
-
10744231895
-
No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients
-
Mabrouk I, Baccouche S, El Abed R, Mokdad-Gargouri R, Mosbah A, Said S, et al. No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann N Y Acad Sci 2003;1010:764-70.
-
(2003)
Ann N Y Acad Sci
, vol.1010
, pp. 764-770
-
-
Mabrouk, I.1
Baccouche, S.2
El Abed, R.3
Mokdad-Gargouri, R.4
Mosbah, A.5
Said, S.6
-
12
-
-
0032506544
-
p53 polymorphism and risk of cervical cancer
-
Helland A, Langerod A, Johnsen H, Olsen AO, Skovlund E, Borresen-Dale AL. p53 polymorphism and risk of cervical cancer. Nature 1998;396:530-1.
-
(1998)
Nature
, vol.396
, pp. 530-531
-
-
Helland, A.1
Langerod, A.2
Johnsen, H.3
Olsen, A.O.4
Skovlund, E.5
Borresen-Dale, A.L.6
-
13
-
-
22344450943
-
Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival
-
Tommiska J, Eerola H, Heinonen M, Salonen L, Kaare M, Tallila J, et al. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival. Clin Cancer Res 2005;11:5098-103.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 5098-5103
-
-
Tommiska, J.1
Eerola, H.2
Heinonen, M.3
Salonen, L.4
Kaare, M.5
Tallila, J.6
-
14
-
-
1642576139
-
Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features
-
Han W, Kang D, Park IA, Kim SW, Bae JY, Chung KW, et al. Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features. Clin Cancer Res 2004;10:124-30.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 124-130
-
-
Han, W.1
Kang, D.2
Park, I.A.3
Kim, S.W.4
Bae, J.Y.5
Chung, K.W.6
-
15
-
-
0036911840
-
The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas
-
Langerod A, Bukholm IR, Bregard A, Lonning PE, Andersen TI, Rognum TO, et al. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. Cancer Epidemiol Biomarkers Prev 2002;11:1684-8.
-
(2002)
Cancer Epidemiol Biomarkers Prev
, vol.11
, pp. 1684-1688
-
-
Langerod, A.1
Bukholm, I.R.2
Bregard, A.3
Lonning, P.E.4
Andersen, T.I.5
Rognum, T.O.6
-
16
-
-
0036606622
-
Effect of germ-line genetic variation on breast cancer survival in a population-based study
-
Goode EL, Dunning AM, Kuschel B, Healey CS, Day NE, Ponder BA, et al. Effect of germ-line genetic variation on breast cancer survival in a population-based study. Cancer Res 2002;62:3052-7.
-
(2002)
Cancer Res
, vol.62
, pp. 3052-3057
-
-
Goode, E.L.1
Dunning, A.M.2
Kuschel, B.3
Healey, C.S.4
Day, N.E.5
Ponder, B.A.6
-
17
-
-
10744224153
-
Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients
-
Bonafe M, Ceccarelli C, Farabegoli F, Santini D, Taffurelli M, Barbi C, et al. Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients. Clin Cancer Res 2003;9:4860-4.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 4860-4864
-
-
Bonafe, M.1
Ceccarelli, C.2
Farabegoli, F.3
Santini, D.4
Taffurelli, M.5
Barbi, C.6
-
18
-
-
0030058617
-
The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry
-
Sjogren S, Inganas M, Norberg T, Lindgren A, Nordgren H, Holmberg L, et al. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. J Natl Cancer Inst 1996;88:173-82.
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 173-182
-
-
Sjogren, S.1
Inganas, M.2
Norberg, T.3
Lindgren, A.4
Nordgren, H.5
Holmberg, L.6
-
19
-
-
0035866772
-
Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer
-
Geisler S, Lonning PE, Aas T, Johnsen H, Fluge O, Haugen DF, et al. Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Cancer Res 2001;61:2505-12.
-
(2001)
Cancer Res
, vol.61
, pp. 2505-2512
-
-
Geisler, S.1
Lonning, P.E.2
Aas, T.3
Johnsen, H.4
Fluge, O.5
Haugen, D.F.6
-
20
-
-
27144536311
-
p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer
-
Xu Y, Yao L, Ouyang T, Li J, Wang T, Fan Z, et al. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer. Clin Cancer Res 2005;11:7328-33.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 7328-7333
-
-
Xu, Y.1
Yao, L.2
Ouyang, T.3
Li, J.4
Wang, T.5
Fan, Z.6
-
21
-
-
0346003770
-
Chalkley estimates of angiogenesis in early breast cancer-relevance to prognosis
-
Offersen BV, Sorensen FB, Yilmaz M, Knoop A, Overgaard J. Chalkley estimates of angiogenesis in early breast cancer-relevance to prognosis. Acta Oncol 2002;41:695-703.
-
(2002)
Acta Oncol
, vol.41
, pp. 695-703
-
-
Offersen, B.V.1
Sorensen, F.B.2
Yilmaz, M.3
Knoop, A.4
Overgaard, J.5
-
22
-
-
0031961112
-
Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement
-
Hansen LL, Andersen J, Overgaard J, Kruse TA. Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement. APMIS 1998;106:371-7.
-
(1998)
APMIS
, vol.106
, pp. 371-377
-
-
Hansen, L.L.1
Andersen, J.2
Overgaard, J.3
Kruse, T.A.4
-
23
-
-
0032523969
-
Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer
-
Hansen LL, Yilmaz M, Overgaard J, Andersen J, Kruse TA. Allelic loss of 16q23.2-24.2 is an independent marker of good prognosis in primary breast cancer. Cancer Res 1998;58:2166-9.
-
(1998)
Cancer Res
, vol.58
, pp. 2166-2169
-
-
Hansen, L.L.1
Yilmaz, M.2
Overgaard, J.3
Andersen, J.4
Kruse, T.A.5
-
24
-
-
0038148257
-
Rapid, accurate genotyping of beta-thalassaemia mutations using a novel multiplex primer extension/denaturing high-performance liquid chromatography assay
-
Wu G, Hua L, Zhu J, Mo QH, Xu XM. Rapid, accurate genotyping of beta-thalassaemia mutations using a novel multiplex primer extension/denaturing high-performance liquid chromatography assay. Br J Haematol 2003;122:311-6.
-
(2003)
Br J Haematol
, vol.122
, pp. 311-316
-
-
Wu, G.1
Hua, L.2
Zhu, J.3
Mo, Q.H.4
Xu, X.M.5
-
25
-
-
0037427560
-
A more accurate detection of codon 72 polymorphism and LOH of the TP53 gene
-
Baccouche S, Mabrouk I, Said S, Mosbah A, Jlidi R, Gargouri A. A more accurate detection of codon 72 polymorphism and LOH of the TP53 gene. Cancer Lett 2003;189:91-6.
-
(2003)
Cancer Lett
, vol.189
, pp. 91-96
-
-
Baccouche, S.1
Mabrouk, I.2
Said, S.3
Mosbah, A.4
Jlidi, R.5
Gargouri, A.6
-
27
-
-
0036330489
-
Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients
-
Hogdall EV, Hogdall CK, Christensen L, Glud E, Blaakaer J, Bock JE, et al. Distribution of p53 codon 72 polymorphisms in ovarian tumour patients and their prognostic significance in ovarian cancer patients. Anticancer Res 2002;22:1859-64.
-
(2002)
Anticancer Res
, vol.22
, pp. 1859-1864
-
-
Hogdall, E.V.1
Hogdall, C.K.2
Christensen, L.3
Glud, E.4
Blaakaer, J.5
Bock, J.E.6
|